Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-04-27

Clinical Trial Update: A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine. [Phase 4]

View source ↗

Summary

This Phase 4 study evaluated three strategies for switching patients with schizophrenia or schizoaffective disorder from olanzapine to risperidone after insuffi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)
  • olanzapine (olanzapine)

Snippet

Sponsor: Janssen, LP | Conditions: Schizoaffective Disorder, Schizophrenia | Phase 4 | Status: COMPLETED